{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:44:56Z","timestamp":1782459896235,"version":"3.54.5"},"reference-count":20,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1053\/j.jvca.2024.03.037","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:53:19Z","timestamp":1711561999000},"page":"1727-1729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Andexanet Alfa\u2013Induced Heparin Resistance: Sustained Anticoagulant Inefficacy Despite Antithrombin Therapy"],"prefix":"10.1053","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-8818","authenticated-orcid":false,"given":"Kohei","family":"Nagashima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junpei","family":"Numari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Yamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikuni","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigefumi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.03.037_bib0001","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCRESAHA.113.302297","article-title":"The real decoy: An antidote for factor Xa-directed anticoagulants","volume":"113","author":"Yeh","year":"2013","journal-title":"Circ Res"},{"key":"10.1053\/j.jvca.2024.03.037_bib0002","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connolly","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.03.037_bib0003","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.athoracsur.2021.03.033","article-title":"STS\/SCA\/AmSECT\/SABM update to the clinical practice guidelines on patient blood management","volume":"112","author":"Tibi","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.03.037_bib0004","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s12028-022-01573-5","article-title":"Andexanet-alfa-associated heparin resistance in the context of hemorrhagic stroke","volume":"37","author":"M\u00fcther","year":"2022","journal-title":"Neurocrit Care"},{"key":"10.1053\/j.jvca.2024.03.037_bib0005","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.jvca.2020.10.042","article-title":"Successful antithrombin administration in andexanet alfa-associated heparin resistance","volume":"35","author":"Apostel","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.03.037_bib0006","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40981-023-00619-7","article-title":"Successful use of an antithrombin for heparin resistance with andexanet alfa","volume":"9","author":"Honda","year":"2023","journal-title":"JA Clin Rep"},{"key":"10.1053\/j.jvca.2024.03.037_bib0007","first-page":"e44003","article-title":"Successful nafamostat mesilate administration for andexanet alfa-induced heparin resistance","volume":"15","author":"Kitaura","year":"2023","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2024.03.037_bib0008","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1510\/icvts.2009.215848","article-title":"Argatroban as a substitute of heparin during cardiopulmonary bypass: A safe alternative?","volume":"10","author":"Follis","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2024.03.037_bib0009","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3400\/avd.cr.22-00082","article-title":"Cardiopulmonary bypass surgery in a patient with unexpected heparin-induced thrombocytopenia","volume":"15","author":"Miyagawa","year":"2022","journal-title":"Ann Vasc Dis"},{"key":"10.1053\/j.jvca.2024.03.037_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40981-020-0310-6","article-title":"Use of argatroban in combination with nafamostat mesilate in open-heart surgery for a pediatric patient with heparin-induced thrombocytopenia type II: A case report","volume":"6","author":"Kawamoto","year":"2020","journal-title":"JA Clin Rep"},{"key":"10.1053\/j.jvca.2024.03.037_bib0011","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajem.2022.02.029","article-title":"Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages","volume":"55","author":"Pham","year":"2022","journal-title":"Am J Emerg Med"},{"key":"10.1053\/j.jvca.2024.03.037_bib0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2217\/fca-2020-0073","article-title":"Real-world management of oral factor Xa inhibitor-related bleeds with reversal or replacement agents including andexanet alfa and four-factor prothrombin complex concentrate: A multicenter study","volume":"17","author":"Coleman","year":"2021","journal-title":"Future Cardiol"},{"key":"10.1053\/j.jvca.2024.03.037_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12028-020-01161-5","article-title":"Andexanet alfa versus 4-factor prothrombin complex concentrate for reversal of factor Xa inhibitors in intracranial hemorrhage","volume":"35","author":"Ammar","year":"2021","journal-title":"Neurocrit Care"},{"key":"10.1053\/j.jvca.2024.03.037_bib0014","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11239-022-02752-z","article-title":"Comparison of 4-factor prothrombin complex concentrate and andexanet alfa for reversal of apixaban and rivaroxaban in the setting of intracranial hemorrhage","volume":"55","author":"Lipski","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2024.03.037_bib0015","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2023.11.015","article-title":"Four-factor prothrombin complex concentrate versus andexanet alfa for direct oral anticoagulant reversal","volume":"64","author":"Koo","year":"2024","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1053\/j.jvca.2024.03.037_bib0016","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s11239-021-02613-1","article-title":"Comparison of 4-factor PCC reversal of apixaban and rivaroxaban versus warfarin for intracranial hemorrhage","volume":"54","author":"Pasciolla","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1053\/j.jvca.2024.03.037_bib0017","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.40145","article-title":"Evaluation of direct oral anticoagulant reversal agents in intracranial hemorrhage: A systematic review and meta-analysis","volume":"5","author":"Chaudhary","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1053\/j.jvca.2024.03.037_bib0018","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1056\/NEJMoa1814051","article-title":"Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors","volume":"380","author":"Connolly","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.03.037_bib0019","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.03.037_bib0020","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.21037\/jtd-22-428","article-title":"Management of perioperative bleeding risk in patients on antithrombotic medications undergoing cardiac surgery-A systematic review","volume":"14","author":"Matejic-Spasic","year":"2022","journal-title":"J Thorac Dis"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024002295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024002295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T01:44:00Z","timestamp":1720835040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024002295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":20,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1053077024002295"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.03.037","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Andexanet Alfa\u2013Induced Heparin Resistance: Sustained Anticoagulant Inefficacy Despite Antithrombin Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.03.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}